Overview of SGLT2 Inhibitors: The Next Longevity Breakthrough?
Scientific investigations have placed significant focus on the longevity outcomes of sglt2 inhibitors: the next longevity breakthrough?. Randomized control trials and cohort analyses demonstrate a clear link to biological pathways including mTOR inhibition, sirtuin activation, and telomere preservation.
Practical Action Plan
Incorporating evidence-based practices from this research helps suppress systemic inflammaging trends and maintain long-term metabolic flexibility.